Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Raphael Pharmaceutical Inc. (RAPH) had Stock-Based Compensation of $0.24M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-1.28M |
|
-- |
|
-- |
|
$1.25M |
|
$-1.25M |
|
$-0.03M |
|
$-1.28M |
|
$-1.28M |
|
$-1.28M |
|
$-1.28M |
|
$-1.28M |
|
$-1.28M |
|
$-1.25M |
|
$-1.25M |
|
19.55M |
|
19.55M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$0.05M |
|
$0.00M |
|
$0.00M |
|
$0.05M |
|
$1.49M |
|
-- |
|
-- |
|
$1.49M |
|
$-1.43M |
|
$-1.43M |
|
$-1.43M |
|
20.18M |
|
| Cash Flow Statement Financials | |
$-0.21M |
|
-- |
|
$0.24M |
|
$0.02M |
|
$0.04M |
|
$0.03M |
|
|
Stock-Based Compensation |
$0.24M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
-- |
|
-0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
89.25% |
|
89.25% |
|
-2413.21% |
|
89.25% |
|
$-0.07 |
|
$-0.01 |
|
$-0.01 |
|